loading

Janux Therapeutics Inc Azioni (JANX) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - 0.439 8.897
Research and Development
38.35%
34.66
25.05 - - -
Operating Income/Loss
29.29%
-45.12
-34.90 -29.02 -35.84 -13.82
Nonoperating Income/Loss
1.13%
11.26
11.39 8.806 7.783 7.863
Income/Loss From Continuing Operations Before Tax
44.03%
-33.86
-23.51 -20.22 -28.06 -5.959
Income/Loss From Continuing Operations After Tax
44.03%
-33.86
-23.51 -20.22 -28.06 -5.959
Net Income/Loss
44.03%
-33.86
-23.51 -20.22 -28.06 -5.959
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.18%
61.90
61.79 1.0345 54.63 54.45
Diluted Average Shares
0.18%
61.90
61.79 1.0345 54.63 54.45
Basic Earnings Per Share
44.74%
-0.55
-0.38 -0.35 -0.51 -0.11
Diluted Earnings Per Share
44.74%
-0.55
-0.38 -0.35 -0.51 -0.11
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$25.14
price up icon 1.47%
$84.24
price down icon 0.76%
$25.43
price up icon 2.60%
$102.25
price down icon 0.74%
$136.57
price up icon 1.43%
biotechnology ONC
$302.15
price up icon 0.67%
Capitalizzazione:     |  Volume (24 ore):